Sadoff JC - Search Results

1

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys.

Putnak R, Barvir DA, Burrous JM, Dubois DR, D'Andrea VM, Hoke CH, Sadoff JC, Eckels KH. Putnak R, et al. Among authors: sadoff jc. J Infect Dis. 1996 Dec;174(6):1176-84. doi: 10.1093/infdis/174.6.1176. J Infect Dis. 1996. PMID: 8940206

2

Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers.

Sanchez JL, Trofa AF, Taylor DN, Kuschner RA, DeFraites RF, Craig SC, Rao MR, Clemens JD, Svennerholm AM, Sadoff JC, et al. Sanchez JL, et al. Among authors: sadoff jc. J Infect Dis. 1993 Jun;167(6):1446-9. doi: 10.1093/infdis/167.6.1446. J Infect Dis. 1993. PMID: 8501336 Clinical Trial.

3

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR, et al. Ockenhouse CF, et al. Among authors: sadoff jc. J Infect Dis. 1998 Jun;177(6):1664-73. doi: 10.1086/515331. J Infect Dis. 1998. PMID: 9607847 Clinical Trial.

4

Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes.

Heppner DG, Gordon DM, Gross M, Wellde B, Leitner W, Krzych U, Schneider I, Wirtz RA, Richards RL, Trofa A, Hall T, Sadoff JC, Boerger P, Alving CR, Sylvester DR, Porter TG, Ballou WR. Heppner DG, et al. Among authors: sadoff jc. J Infect Dis. 1996 Aug;174(2):361-6. doi: 10.1093/infdis/174.2.361. J Infect Dis. 1996. PMID: 8699067

5

Safety and immunogenicity of a polyvalent Escherichia coli vaccine in human volunteers.

Cross A, Artenstein A, Que J, Fredeking T, Furer E, Sadoff JC, Cryz SJ Jr. Cross A, et al. Among authors: sadoff jc. J Infect Dis. 1994 Oct;170(4):834-40. doi: 10.1093/infdis/170.4.834. J Infect Dis. 1994. PMID: 7523536 Clinical Trial.

6

Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.

Taylor DN, Cárdenas V, Sanchez JL, Bégué RE, Gilman R, Bautista C, Perez J, Puga R, Gaillour A, Meza R, Echeverria P, Sadoff J. Taylor DN, et al. J Infect Dis. 2000 May;181(5):1667-73. doi: 10.1086/315462. Epub 2000 May 15. J Infect Dis. 2000. PMID: 10823767 Clinical Trial.

7

A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.

Bhattacharjee AK, Opal SM, Taylor R, Naso R, Semenuk M, Zollinger WD, Moran EE, Young L, Hammack C, Sadoff JC, Cross AS. Bhattacharjee AK, et al. Among authors: sadoff jc. J Infect Dis. 1996 May;173(5):1157-63. doi: 10.1093/infdis/173.5.1157. J Infect Dis. 1996. PMID: 8627067

8

Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilin.

Johnson SC, Chung RC, Deal CD, Boslego JW, Sadoff JC, Wood SW, Brinton CC Jr, Tramont EC. Johnson SC, et al. Among authors: sadoff jc. J Infect Dis. 1991 Jan;163(1):128-34. doi: 10.1093/infdis/163.1.128. J Infect Dis. 1991. PMID: 1701817 Clinical Trial.

9

Oral ciprofloxacin and a monoclonal antibody to lipopolysaccharide protect leukopenic rats from lethal infection with Pseudomonas aeruginosa.

Collins HH, Cross AS, Dobek A, Opal SM, McClain JB, Sadoff JC. Collins HH, et al. Among authors: sadoff jc. J Infect Dis. 1989 Jun;159(6):1073-82. doi: 10.1093/infdis/159.6.1073. J Infect Dis. 1989. PMID: 2723454

10

The human antibody response during natural bacteremic infection with gram-negative bacilli against lipopolysaccharide core determinants.

Cross AS, Sidberry H, Sadoff JC. Cross AS, et al. Among authors: sadoff jc. J Infect Dis. 1989 Aug;160(2):225-36. doi: 10.1093/infdis/160.2.225. J Infect Dis. 1989. PMID: 2474616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page